Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
58.08 M
About GENOCEA BIOSCIENCES INC
Sector
Industry
Headquarters
Cambridge
Website
Founded
2006
FIGI
BBG005TXPMR9
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GNCAQ is 0.000001 USD — it hasn't changed in the past 24 hours. Watch GENOCEA BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GENOCEA BIOSCIENCES INC stocks are traded under the ticker GNCAQ.
GNCAQ stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in GENOCEA BIOSCIENCES INC price.
GNCAQ reached its all-time high on Mar 10, 2014 with the price of 191.920000 USD, and its all-time low was 0.000001 USD and was reached on Jul 10, 2023. View more price dynamics on GNCAQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GNCAQ stock is 0.00% volatile and has beta coefficient of −129.09. Track GENOCEA BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is GENOCEA BIOSCIENCES INC there?
Yes, you can track GENOCEA BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
GENOCEA BIOSCIENCES INC is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
No, GNCAQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GNCAQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOCEA BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOCEA BIOSCIENCES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOCEA BIOSCIENCES INC stock shows the sell signal. See more of GENOCEA BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.